Spravato®RegistergeprüftModell benannter Zentren

Privatklinik Meiringen

Meiringen, Schweiz

Behandlung & Zugang

Verwandte Einträge

Diese Einträge gehören zur selben Organisation. Sie werden separat geführt, weil jeder ein eigenes Programm oder ein eigener Standort ist.

Über diesen Anbieter

Details auf Englisch.

Privatklinik Meiringen is a private psychiatric clinic in the Bernese Oberland (Willigen, Meiringen) with core competencies in depression, alcohol and medication dependence and stress-related illness/burnout. Among its extended therapy procedures it explicitly offers ketamine therapy: intravenous and nasal ketamine as well as S-ketamine (Swissmedic-approved since 2020) for patients with treatment-resistant depression, with close monitoring and careful medical assessment of the indication; the same programme mentions participation options in a multicenter study of oral extended-release ketamine. The clinic also runs centres for old-age psychiatry, behavioural addictions and burnout.

Leistungen & Programme

Details auf Englisch.

  • Ketamine therapy (intravenous and nasal) and S-ketamine for treatment-resistant depression
  • Extended therapy procedures programme
  • Inpatient treatment of depression, alcohol and medication dependence
  • Centre for stress-related illness/burnout
  • Centre for behavioural addictions
  • Centre for old-age psychiatry
  • Psychiatry centre for young adults (PZJE Thun)
  • Outpatient services and mother-child care option

Häufige Fragen

Details auf Englisch.

Who decides whether I can receive ketamine or esketamine at Privatklinik Meiringen?

Per the clinic, the indication is carefully assessed and weighed by its physicians, and treatments are closely monitored; a named senior physician is listed as contact via the main line +41 33 972 81 11. Referral by your treating psychiatrist is the standard route.

What insurance conditions apply for the nasal spray (Spravato)?

Under the BAG Limitatio, basic insurance covers esketamine nasal spray for adults 18-74 with treatment-resistant depression (at least two antidepressants with different mechanisms plus one augmentation attempt failed, confirmed severity) only after the insurer's cost approval (Kostengutsprache), for a maximum of 10 months.

Alternativen im Blick? One of the BAG-designated Spravato centers in Switzerland; see the country guide and the limited-medical-use PAT program.

Verifizierung

Dieser Eintrag stammt direkt aus einem offiziellen Register oder einer Programmliste und wird in rollierendem Turnus erneut geprüft.

Einen Fehler entdeckt? Siehe unsere Methodik (auf Englisch) — dort steht, wie Einträge geprüft werden und wie Sie eine Korrektur melden.